People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AgeX Therapeutics, Inc. | — | Biotechnology | Series A | $19.0M | $162.7M | 2018 |
John H. Mauldin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John H. Mauldin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael D West | 1 | 6 |
| Alfred D Kingsley | 1 | 6 |
| Michael H. Mulroy | 1 | 2 |
| Russell D. Skibsted | 1 | 1 |
| Annalisa F. Jenkins | 1 | 1 |
| John F. Mauldin | 1 | 1 |
| Gregory D. Bailey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.